{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:31:05Z","timestamp":1786681865379,"version":"build-2736575974"},"reference-count":25,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>The COVID-19 pandemic shifted pediatric infection epidemiology from bacterial toward viral predominance as public health measures relaxed. To determine how hospital antibiotic prescribing adapted, antimicrobial consumption was characterized and linked to underlying pathogen type. Antibiotic use was retrospectively analyzed among 567 children admitted with a positive microbiological finding to the pediatric ward of a tertiary hospital in Split, Croatia, during the first quarters of 2021\u20132024. Consumption was quantified using Days of Therapy (DOT), Length of Therapy (LOT), and Days of Antibiotic Spectrum Coverage (DASC) per 1000 patient-days (PD). Antibiotics were grouped by the WHO Access\/Watch\/Reserve (AWaRe) classification and linked to discharge diagnosis and pathogen type. The proportion of children receiving antibiotics rose from 60.5% (26\/43) in 2021 to 71.4% (130\/182) in 2024, with the cohort shifting toward younger infants and virally driven diagnoses. DOT, DASC, and DOT\/LOT peaked in 2022 (DOT 2164\/1000 PD, DOT\/LOT 2.2) before settling near 1400\/1000 PD, with mean per-day spectrum (DASC\/DOT) declining modestly (7.7 to 6.8). Watch-group antibiotics dominated throughout (~80%), with Access contribution of ~20% and Reserve antibiotic use negligible. Ceftriaxone usage rose fivefold (150 to 755 DOT\/1000 PD) to become the leading agent. Ceftriaxone and azithromycin were administered more often to children with viral than bacterial infections (respiratory syncytial virus being most common), whereas vancomycin and meropenem were tied to bacterial isolates. These findings identify a high-yield stewardship target and underscore the value of multi-metric, pathogen-aware surveillance.<\/jats:p>","DOI":"10.3390\/pathogens15080841","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:17:52Z","timestamp":1786551472000},"page":"841","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial Consumption and Prescribing Patterns in Hospitalized Children During and After the COVID-19 Pandemic"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3689-2119","authenticated-orcid":false,"given":"Sandra","family":"Prgomet","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University Hospital Centre Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-3149","authenticated-orcid":false,"given":"Danica","family":"Boban","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-0120","authenticated-orcid":false,"given":"Zvonimir","family":"Boban","sequence":"additional","affiliation":[{"name":"Department of Medical Physics and Biophysics, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Boban","sequence":"additional","affiliation":[{"name":"Department of Hospital Infections and Clinical Epidemiology, University Hospital Split, 21000 Split, Croatia"},{"name":"Department of Public Health, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global Burden of Bacterial Antimicrobial Resistance 1990\u20132021: A Systematic Analysis with Forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kalasikam, M., Jimenez-Truque, N., Kloek, A.B., and Banerjee, R. (2025). Antibiotic Overuse in a Contemporary Cohort of Children Hospitalized with Influenza, RSV, or SARS-CoV-2: A Retrospective Cohort Study. BMC Pediatr., 25.","DOI":"10.1186\/s12887-025-06165-8"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jgar.2021.10.015","article-title":"Unnecessary Antibiotic Treatment of Children Hospitalised with Respiratory Syncytial Virus (RSV) Bronchiolitis: Risk Factors and Prescription Patterns","volume":"27","author":"Obolski","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_5","unstructured":"(2026, June 10). WHO Reports Widespread Overuse of Antibiotics in Patients Hospitalized with COVID-19. Available online: https:\/\/www.who.int\/news\/item\/26-04-2024-who-reports-widespread-overuse-of-antibiotics-in-patients--hospitalized-with-covid-19."},{"key":"ref_6","unstructured":"(2022). The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book, World Health Organization. [1st ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jac\/dkab050","article-title":"The Global-PPS network Hospital Antibiotic Prescribing Patterns in Adult Patients According to the WHO Access, Watch and Reserve Classification (AWaRe): Results from a Worldwide Point Prevalence Survey in 69 Countries","volume":"76","author":"Pauwels","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(20)30332-7","article-title":"Assessment of WHO Antibiotic Consumption and Access Targets in 76 Countries, 2000\u20132015: An Analysis of Pharmaceutical Sales Data","volume":"21","author":"Klein","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/cid\/ciab1034","article-title":"Days of Antibiotic Spectrum Coverage: A Novel Metric for Inpatient Antibiotic Consumption","volume":"75","author":"Kakiuchi","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1017\/ice.2024.137","article-title":"Antibiotic Spectrum Coverage Scoring as a Potential Metric for Evaluating the Antimicrobial Stewardship Team Activity: A Single-Center Study","volume":"45","author":"Oda","year":"2024","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Prgomet, S., Boban, Z., Prgomet, S., and Boban, N. (2025). Epidemiological and Clinical Characteristics of Infections in Hospitalized Children During and After the COVID-19 Pandemic. Viruses, 17.","DOI":"10.3390\/v17101296"},{"key":"ref_12","unstructured":"R Core Team (2026). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/cran.r-project.org\/manuals.html."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.annemergmed.2021.01.003","article-title":"Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections","volume":"78","author":"Mark","year":"2021","journal-title":"Ann. Emerg. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dur\u00e0-Miralles, X., Abelenda-Alonso, G., Bergas, A., Laporte-Amarg\u00f3s, J., Sastre-Escol\u00e0, E., Padull\u00e9s, A., Carratal\u00e0, J., and Gudiol, C. (2024). An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19. Antibiotics, 13.","DOI":"10.3390\/antibiotics13010055"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1016\/S2214-109X(19)30071-3","article-title":"Use of the WHO Access, Watch, and Reserve Classification to Define Patterns of Hospital Antibiotic Use (AWaRe): An Analysis of Paediatric Survey Data from 56 Countries","volume":"7","author":"Hsia","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bianchi, M., Rubeo, A., Costa, M., Ferretti, A., Di Nardo, G., Parisi, P., and Ventresca, S. (2026). Pediatric Antimicrobial Stewardship: Current Evidence and Emerging Challenges. Pandemics, 1.","DOI":"10.3390\/pandemics1010004"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Balapasheva, A., Ziganshina, L., Mussina, A., Smagulova, G., Kulnazarova, M., and Balymbetova, L. (2024). Comparative Assessment of Antibacterial Drugs Used at the Hospital Level before and during COVID-19, According to the WHO AWaRe Classification. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1642830"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"s28","DOI":"10.1017\/ash.2023.252","article-title":"Antibiotic Use among SARI Patients According to the AWaRe Classification before and during the COVID-19 Pandemic in Bangladesh","volume":"3","author":"Islam","year":"2023","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103660","DOI":"10.1016\/j.eclinm.2025.103660","article-title":"Rethinking the WHO AWaRe Classification: The Need for More Detailed Guidance","volume":"90","author":"Tsuzuki","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102885","DOI":"10.1016\/j.jiac.2025.102885","article-title":"Limitations of the AWaRe Antibiotic Classification during the 2024 Mycoplasma Pneumoniae Epidemic in Tokyo","volume":"32","author":"Otsubo","year":"2026","journal-title":"J. Infect. Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cpt.1857","article-title":"Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19","volume":"108","author":"Damle","year":"2020","journal-title":"Clin. Pharma Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Galistiani, G.F., Benk\u0151, R., Babarczy, B., Papp, R., Hajdu, \u00c1., Szab\u00f3, \u00c9.H., Viola, R., Papfalvi, E., Visnyovszki, \u00c1., and Matuz, M. (2022). Prescribing Patterns and Variations of Antibiotic Use for Children in Ambulatory Care: A Nationwide Study. Antibiotics, 11.","DOI":"10.3390\/antibiotics11020189"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e1.53","DOI":"10.1136\/archdischild-2015-310148.57","article-title":"Seasonal Variations in Antibiotic Consumption in Paediatric Primary Care Settings in Serbia","volume":"101","year":"2016","journal-title":"Arch. Dis. Child"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jac\/dkg302","article-title":"the Emilia Romagna Study Group on the Use of Antibiotics in Children Antibiotic Prescriptions in Children","volume":"52","author":"Resi","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/ice.2019.338","article-title":"Population-Based Assessment of Patient and Provider Characteristics Influencing Pediatric Outpatient Antibiotic Use in a High Antibiotic-Prescribing State","volume":"41","author":"Katz","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/8\/841\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:25:20Z","timestamp":1786681520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/8\/841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pathogens15080841"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15080841","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}